Dr. Coen is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
50 Maude St
Providence, RI 02908Phone+1 401-456-2690Fax+1 401-456-6540
Education & Training
- Brigham and Women's Hospital/Massachusetts General Hospital/Harvard Medical SchoolResidency, Radiation Oncology, 1999 - 2003
- Virginia Mason Franciscan HealthInternship, Transitional Year, 1998 - 1999
- University of Massachusetts Medical SchoolClass of 1998
Certifications & Licensure
- NH State Medical License 2007 - Present
- MA State Medical License 2003 - 2026
- RI State Medical License 2014 - 2026
- CT State Medical License 2011 - 2015
- WA State Medical License 1998 - 1999
- American Board of Radiology Radiation Oncology
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification ARIA Radiation Oncology EMR, Varian Medical Systems, 2014
Publications & Presentations
PubMed
- 295 citationsLong-Term Outcomes of Selective Bladder Preservation by Combined-Modality Therapy for Invasive Bladder Cancer: The MGH ExperienceJason A. Efstathiou, Daphna Y. Spiegel, William U. Shipley, Niall M. Heney, Donald S. Kaufman
European Urology. 2012-04-01 - 70 citationsBladder Preservation With Twice-a-Day Radiation Plus Fluorouracil/Cisplatin or Once Daily Radiation Plus Gemcitabine for Muscle-Invasive Bladder Cancer: NRG/RTOG 0712-...John J. Coen, Peixin Zhang, Philip J. Saylor, Cheryl T. Lee, Chin-Lee Wu
Journal of Clinical Oncology. 2019-01-01 - 559 citationsRandomized Trial Comparing Conventional-Dose With High-Dose Conformal Radiation Therapy in Early-Stage Adenocarcinoma of the Prostate: Long-Term Results From Proton Ra...Anthony L. Zietman, Kyounghwa Bae, Jerry D. Slater, William U. Shipley, Jason A. Efstathiou
Journal of Clinical Oncology. 2010-03-01
Press Mentions
- Evaluating Two RT-plus-Chemotherapy Strategies in Bladder Cancer Patients Undergoing Bladder SurgeryMarch 7th, 2018
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: